ＴＥＩＰＰペプチド変異体およびその使用 - ACADEMISCH ZIEKENHUIS LEIDEN H.O.D.N. LUMC

Title:

ＴＥＩＰＰペプチド変異体およびその使用

Document Type and Number:

Japanese Patent JP2023505099

Kind Code:

A

Abstract:

例えば、ＨＬＡクラスＩ抗原提示の損傷と関連するがんまたはウイルス感染症の予防または処置において、医薬品として有用である、新規な核酸配列、ベクター、細胞、結合剤、ペプチド、および医薬組成物が、提供される。対応する方法および使用もまた、提供される。

More Like This:

WO/2019/051100	COMPOSITIONS AND PROCESSES FOR TARGETED DELIVERY, EXPRESSION AND MODULATION OF CODING RIBONUCLEIC ACIDS IN TISSUE
JP2023071746	SINGLE NUCLEOTIDE ANALYTICAL METHOD AND ASSOCIATED PROBES
WO/2004/038003	HUMAN POLYPEPTIDES ENCODED BY POLYNUCLEOTIDES AND METHODS OF THEIR USE

Inventors:

Van Gaal, Torwald
Van der Burg, Schult Henriks
Marito, Kuhn

Application Number:

JP2022531591A

Publication Date:

February 08, 2023

Filing Date:

November 25, 2020

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ACADEMISCH ZIEKENHUIS LEIDEN H.O.D.N. LUMC

International Classes:

C12N15/11; A61K35/76; A61K38/08; A61K38/10; A61K38/16; A61K39/00; A61K48/00; A61P31/12; A61P35/00; C07K7/06; C12N1/15; C12N1/19; C12N1/21; C12N5/0781; C12N5/0784; C12N5/0786; C12N5/10; C12N15/63; C12P21/02

Attorney, Agent or Firm:

Yamato Kento
Norifumi Tomita
Fumio Inai
Manami Sasakura
Yusuke Shirae

Previous Patent: Engineered bacterial compositions and uses thereof

Next Patent: Shared RAS inhibitors and uses thereof